Bastide Le Confort Médical SA

ENXTPA:BLC Stock Report

Market Cap: €133.3m

Bastide Le Confort Médical Future Growth

Future criteria checks 3/6

Bastide Le Confort Médical is forecast to grow earnings and revenue by 40.6% and 5.7% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 19.4% in 3 years.

Key information

40.6%

Earnings growth rate

41.0%

EPS growth rate

Healthcare earnings growth23.1%
Revenue growth rate5.7%
Future return on equity19.4%
Analyst coverage

Low

Last updated22 Apr 2024

Recent future growth updates

Recent updates

Is Now An Opportune Moment To Examine Bastide Le Confort Médical SA (EPA:BLC)?

Apr 27
Is Now An Opportune Moment To Examine Bastide Le Confort Médical SA (EPA:BLC)?

Investors Can Find Comfort In Bastide Le Confort Médical's (EPA:BLC) Earnings Quality

Apr 06
Investors Can Find Comfort In Bastide Le Confort Médical's (EPA:BLC) Earnings Quality

Benign Growth For Bastide Le Confort Médical SA (EPA:BLC) Underpins Stock's 26% Plummet

Mar 28
Benign Growth For Bastide Le Confort Médical SA (EPA:BLC) Underpins Stock's 26% Plummet

Positive Sentiment Still Eludes Bastide Le Confort Médical SA (EPA:BLC) Following 28% Share Price Slump

Feb 08
Positive Sentiment Still Eludes Bastide Le Confort Médical SA (EPA:BLC) Following 28% Share Price Slump

The Return Trends At Bastide Le Confort Médical (EPA:BLC) Look Promising

Nov 18
The Return Trends At Bastide Le Confort Médical (EPA:BLC) Look Promising

What Is Bastide Le Confort Médical SA's (EPA:BLC) Share Price Doing?

May 17
What Is Bastide Le Confort Médical SA's (EPA:BLC) Share Price Doing?

Bastide Le Confort Médical (EPA:BLC) Is Doing The Right Things To Multiply Its Share Price

Jan 27
Bastide Le Confort Médical (EPA:BLC) Is Doing The Right Things To Multiply Its Share Price

Is Bastide Le Confort Médical SA (EPA:BLC) Potentially Undervalued?

Nov 22
Is Bastide Le Confort Médical SA (EPA:BLC) Potentially Undervalued?

Bastide Le Confort Médical (EPA:BLC) Is Reinvesting At Lower Rates Of Return

Sep 21
Bastide Le Confort Médical (EPA:BLC) Is Reinvesting At Lower Rates Of Return

Is It Time To Consider Buying Bastide Le Confort Médical SA (EPA:BLC)?

Jul 28
Is It Time To Consider Buying Bastide Le Confort Médical SA (EPA:BLC)?

When Should You Buy Bastide Le Confort Médical SA (EPA:BLC)?

Mar 18
When Should You Buy Bastide Le Confort Médical SA (EPA:BLC)?

Be Wary Of Bastide Le Confort Médical (EPA:BLC) And Its Returns On Capital

May 16
Be Wary Of Bastide Le Confort Médical (EPA:BLC) And Its Returns On Capital

Here's Why Bastide Le Confort Médical (EPA:BLC) Has A Meaningful Debt Burden

Apr 30
Here's Why Bastide Le Confort Médical (EPA:BLC) Has A Meaningful Debt Burden

We Think Bastide Le Confort Médical's (EPA:BLC) Profit Is Only A Baseline For What They Can Achieve

Apr 07
We Think Bastide Le Confort Médical's (EPA:BLC) Profit Is Only A Baseline For What They Can Achieve

Should You Think About Buying Bastide Le Confort Médical SA (EPA:BLC) Now?

Mar 10
Should You Think About Buying Bastide Le Confort Médical SA (EPA:BLC) Now?

Is Bastide Le Confort Médical SA's (EPA:BLC) 16% ROE Better Than Average?

Feb 21
Is Bastide Le Confort Médical SA's (EPA:BLC) 16% ROE Better Than Average?

Bastide Le Confort Médical SA's (EPA:BLC) Intrinsic Value Is Potentially 33% Above Its Share Price

Feb 07
Bastide Le Confort Médical SA's (EPA:BLC) Intrinsic Value Is Potentially 33% Above Its Share Price

Earnings and Revenue Growth Forecasts

ENXTPA:BLC - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20266012633943
6/30/20255642327873
6/30/20245301726783
12/31/202352363488N/A
9/30/2023516114397N/A
6/30/20235081652106N/A
12/31/2022495181568N/A
9/30/202248216963N/A
6/30/202246814457N/A
12/31/2021446133381N/A
9/30/2021445133178N/A
6/30/2021444132874N/A
3/31/2021436121965N/A
12/31/2020428111155N/A
9/30/202040511951N/A
6/30/202038312847N/A
3/31/202036591655N/A
12/31/201934772562N/A
9/30/201934162662N/A
6/30/201933662761N/A
3/31/201932872258N/A
12/31/201832191856N/A
9/30/201830581553N/A
6/30/201828971250N/A
3/31/20182676743N/A
12/31/20172455135N/A
9/30/20172325N/A31N/A
6/30/20172185N/A26N/A
3/31/20172116N/A26N/A
12/31/20162037N/A25N/A
9/30/20161987N/A28N/A
6/30/20161927N/A32N/A
3/31/20161877N/A32N/A
12/31/20151827N/A32N/A
9/30/20151777N/A28N/A
6/30/20151717N/A24N/A
3/31/20151667N/AN/AN/A
12/31/20141606N/A19N/A
9/30/20141566N/A19N/A
6/30/20141525N/A18N/A
3/31/20141485N/AN/AN/A
12/31/20131435N/A19N/A
9/30/20131394N/A19N/A
6/30/20131344N/A19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BLC's forecast earnings growth (40.6% per year) is above the savings rate (1.1%).

Earnings vs Market: BLC's earnings (40.6% per year) are forecast to grow faster than the French market (10.9% per year).

High Growth Earnings: BLC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BLC's revenue (5.7% per year) is forecast to grow slower than the French market (5.7% per year).

High Growth Revenue: BLC's revenue (5.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BLC's Return on Equity is forecast to be low in 3 years time (19.4%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.